+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cryptococcosis Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030

  • PDF Icon

    Report

  • 118 Pages
  • August 2022
  • Region: Global
  • Acute Market Reports
  • ID: 5668810
Cryptococcosis is a potentially fatal fungal disease occurs due to Cryptococcus. Factors such, increase in prevalence of fatal fungal disease, rising treatment awareness and last-stage HIV patients developing the disease are driving the growth of Cryptococcosis market worldwide.

The report titled Cryptococcosis Market - Growth, Future Prospects and Competitive Analysis, 2022-2030 offers strategic insights into the overall Cryptococcosis market along with the market size and estimates for the duration 2020 to 2030. The research study covers in-depth analysis of market segments based on treatment type (Amphotericin B, Flucytosine, Fluconazole and Others treatment options) and different geographical regions.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global Cryptococcosis market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global Cryptococcosis market. This report concludes with company profiles section that highlights major information about the key players engaged in global Cryptococcosis market. In-depth competitive environment analysis and historical years (2015) market size data are also provided in the report.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Cryptococcosis market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Cryptococcosis market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Treatment

  • Amphotericin B
  • Flucytosine
  • Fluconazole
  • Other (Voriconazole, surgery treatment, etc.)

Key Questions Answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Cryptococcosis market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Cryptococcosis market?
  • Which is the largest regional market for Cryptococcosis market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Cryptococcosis market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Cryptococcosis market worldwide?


This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Cryptococcosis Market
2.2. Global Cryptococcosis Market, By Treatment, 2021 (US$ Million)
2.3. Global Cryptococcosis Market, By Geography, 2021 (US$ Million)
2.4. Impact of Covid 19
2.5. Attractive Investment Proposition by Geography, 2021
2.6. Competitive Analysis
2.6.1. Market Positioning of Key Cryptococcosis Market Vendors
2.6.2. Strategies Adopted by Cryptococcosis Market Vendors
2.6.3. Key Industry Strategies
3. Cryptococcosis Market: Business Outlook & Market Dynamics
3.1. Introduction
3.2. Global Cryptococcosis Market Value, 2020 - 2030, (US$ Million)
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.2. Market Restraints
3.3.3. Key Challenges
3.3.4. Key Opportunities
3.4. Impact Analysis of Drivers and Restraints
3.5. See-Saw Analysis
3.6. Porter’s Five Force Model
3.6.1. Supplier Power
3.6.2. Buyer Power
3.6.3. Threat Of Substitutes
3.6.4. Threat Of New Entrants
3.6.5. Competitive Rivalry
3.7. PESTEL Analysis
3.7.1. Political Landscape
3.7.2. Economic Landscape
3.7.3. Technology Landscape
3.7.4. Legal Landscape
3.7.5. Social Landscape
4. Cryptococcosis Market: By Treatment, 2020-2030, USD (Million)
4.1. Market Overview
4.2. Growth & Revenue Analysis: 2021 Versus 2030
4.3. Market Segmentation
4.3.1. Amphotericin B
4.3.2. Flucytosine
4.3.3. Fluconazole
4.3.4. Other (Voriconazole, surgery treatment, etc.)
5. North America Cryptococcosis Market, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Cryptococcosis Market: By Treatment, 2020-2030, USD (Million)
5.3.Cryptococcosis Market: By Region, 2020-2030, USD (Million)
5.3.1.North America
5.3.1.1. U.S.
5.3.1.2. Canada
5.3.1.3. Rest of North America
6. UK and European Union Cryptococcosis Market, 2020-2030, USD (Million)
6.1. Market Overview
6.2. Cryptococcosis Market: By Treatment, 2020-2030, USD (Million)
6.3.Cryptococcosis Market: By Region, 2020-2030, USD (Million)
6.3.1.UK and European Union
6.3.1.1. UK
6.3.1.2. Germany
6.3.1.3. Spain
6.3.1.4. Italy
6.3.1.5. France
6.3.1.6. Rest of Europe
7. Asia Pacific Cryptococcosis Market, 2020-2030, USD (Million)
7.1. Market Overview
7.2. Cryptococcosis Market: By Treatment, 2020-2030, USD (Million)
7.3.Cryptococcosis Market: By Region, 2020-2030, USD (Million)
7.3.1.Asia Pacific
7.3.1.1. China
7.3.1.2. Japan
7.3.1.3. India
7.3.1.4. Australia
7.3.1.5. South Korea
7.3.1.6. Rest of Asia Pacific
8. Latin America Cryptococcosis Market, 2020-2030, USD (Million)
8.1. Market Overview
8.2. Cryptococcosis Market: By Treatment, 2020-2030, USD (Million)
8.3.Cryptococcosis Market: By Region, 2020-2030, USD (Million)
8.3.1.Latin America
8.3.1.1. Brazil
8.3.1.2. Mexico
8.3.1.3. Rest of Latin America
9. Middle East and Africa Cryptococcosis Market, 2020-2030, USD (Million)
9.1. Market Overview
9.2. Cryptococcosis Market: By Treatment, 2020-2030, USD (Million)
9.3.Cryptococcosis Market: By Region, 2020-2030, USD (Million)
9.3.1.Middle East and Africa
9.3.1.1. GCC
9.3.1.2. Africa
9.3.1.3. Rest of Middle East and Africa
10. Company Profile
10.1. Abbott Laboratories
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Portfolio
10.1.4. Strategic Initiatives
10.2. Alkopharma Inc.
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Portfolio
10.2.4. Strategic Initiatives
10.3. Astellas Pharma Inc.
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Portfolio
10.3.4. Strategic Initiatives
10.4. Bristol-Myers Squibb Company
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Portfolio
10.4.4. Strategic Initiatives
10.5. Glenmark Pharmaceuticals
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Portfolio
10.5.4. Strategic Initiatives
10.6. Janssen Biotech, Inc. (a Johnson & Johnson)
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Portfolio
10.6.4. Strategic Initiatives
10.7. Novartis AG
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Portfolio
10.7.4. Strategic Initiatives
10.8. Pfizer Inc.
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Portfolio
10.8.4. Strategic Initiatives
10.9. Sigmapharm Laboratories LLC.
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Portfolio
10.9.4. Strategic Initiatives
10.10. Valeant Pharmaceuticals, Inc.
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Portfolio
10.10.4. Strategic Initiatives
List of Figures
Figure 1. Global Cryptococcosis Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Cryptococcosis Market: Quality Assurance
Figure 5 Global Cryptococcosis Market, By Treatment, 2021
Figure 6 Global Cryptococcosis Market, By Geography, 2021
Figure 7 Global Cryptococcosis Market, By Treatment, 2021 Vs 2030, %
Figure 8 U.S. Cryptococcosis Market (US Million), 2020 - 2030
Figure 9 Canada Cryptococcosis Market (US Million), 2020 - 2030
Figure 10 Rest of North America Cryptococcosis Market (US Million), 2020 - 2030
Figure 11 UK Cryptococcosis Market (US Million), 2020 - 2030
Figure 12 Germany Cryptococcosis Market (US Million), 2020 - 2030
Figure 13 Spain Cryptococcosis Market (US Million), 2020 - 2030
Figure 14 Italy Cryptococcosis Market (US Million), 2020 - 2030
Figure 15 France Cryptococcosis Market (US Million), 2020 - 2030
Figure 16 Rest of Europe Cryptococcosis Market (US Million), 2020 - 2030
Figure 17 China Cryptococcosis Market (US Million), 2020 - 2030
Figure 18 Japan Cryptococcosis Market (US Million), 2020 - 2030
Figure 19 India Cryptococcosis Market (US Million), 2020 - 2030
Figure 20 Australia Cryptococcosis Market (US Million), 2020 - 2030
Figure 21 South Korea Cryptococcosis Market (US Million), 2020 - 2030
Figure 22 Rest of Asia Cryptococcosis Market (US Million), 2020 - 2030
Figure 23 Brazil Cryptococcosis Market (US Million), 2020 - 2030
Figure 24 Mexico Cryptococcosis Market (US Million), 2020 - 2030
Figure 25 Rest of Latin America Cryptococcosis Market (US Million), 2020 - 2030
Figure 26 GCC Cryptococcosis Market (US Million), 2020 - 2030
Figure 27 Africa Cryptococcosis Market (US Million), 2020 - 2030
Figure 28 Rest of Middle East and Africa Cryptococcosis Market (US Million), 2020 - 2030
List of Tables
Table 1 Global Cryptococcosis Market By Treatment, 2020-2030, USD (Million)
Table 2 North America Cryptococcosis Market By Treatment, 2020-2030, USD (Million)
Table 3 UK and European Union Cryptococcosis Market By Treatment, 2020-2030, USD (Million)
Table 4 Asia Pacific Cryptococcosis Market By Treatment, 2020-2030, USD (Million)
Table 5 Latin America Cryptococcosis Market By Treatment, 2020-2030, USD (Million)
Table 6 Middle East and Africa Cryptococcosis Market By Treatment, 2020-2030, USD (Million)

Companies Mentioned

  • Abbott Laboratories
  • Alkopharma Inc.
  • Astellas Pharma Inc.
  • Bristol-Myers Squibb Company
  • Glenmark Pharmaceuticals
  • Janssen Biotech Inc. (a Johnson & Johnson)
  • Novartis AG
  • Pfizer Inc.
  • Sigmapharm Laboratories LLC.
  • Valeant Pharmaceuticals Inc.